| NERV Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NERV shares outstanding history going back to 6/26/2014:
Also see: NERV Market Cap History NERV YTD Return |
NERV Shares Outstanding History — Minerva Neurosciences Share Count Over Time
As of 3/6/2026 Minerva Neurosciences has 43.27 million NERV shares outstanding. Investors often track the NERV shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NERV share count trends over time, with 49 historical shares outstanding datapoints presented, dating back to 6/26/2014.
| NERV Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NERV Historical Shares Outstanding: +29.45% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NERV Stock Price Chart |
| About Minerva Neurosciences Inc |
| Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. It is engaged in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and have exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson's disease. It has also co-developed seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD). We show 49 historical shares outstanding datapoints in our coverage of NERV's shares outstanding history. Understanding the changing numbers of NERV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NERV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NERV by allowing them to research NERV shares outstanding history as well as any other stock in our coverage universe. |
| NERV Current Stock Quote |
Quotes delayed 20 minutes  Free NERV Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NERV Share Performance |
| Shares Outstanding Peers |
| Minerva Neurosciences (NERV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NEUP Shares Outstanding History NEXI Shares Outstanding History NGM Shares Outstanding History NK Shares Outstanding History NKGN Shares Outstanding History NKTR Shares Outstanding History NKTX Shares Outstanding History NLNK Shares Outstanding History NLTX Shares Outstanding History NMRA Shares Outstanding History More Healthcare companies » |
NERV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
